Mester J - Search Results

1

Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities.

Villerbu N, Gaben AM, Redeuilh G, Mester J. Villerbu N, et al. Among authors: mester j. Int J Cancer. 2002 Feb 20;97(6):761-9. doi: 10.1002/ijc.10125. Int J Cancer. 2002. PMID: 11857351

2

Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.

Gaben AM, Saucier C, Bedin M, Barbu V, Mester J. Gaben AM, et al. Among authors: mester j. Int J Cancer. 2004 Jan 10;108(2):200-6. doi: 10.1002/ijc.11521. Int J Cancer. 2004. PMID: 14639603

3

Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest.

Bedin M, Gaben AM, Saucier C, Mester J. Bedin M, et al. Among authors: mester j. Int J Cancer. 2004 May 1;109(5):643-52. doi: 10.1002/ijc.20010. Int J Cancer. 2004. PMID: 14999769

4

Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.

Gaben AM, Sabbah M, Redeuilh G, Bedin M, Mester J. Gaben AM, et al. Among authors: mester j. BMC Cancer. 2012 Jul 16;12:291. doi: 10.1186/1471-2407-12-291. BMC Cancer. 2012. PMID: 22799881 Free PMC article.

5

Proliferation of breast cancer cells: regulation, mediators, targets for therapy.

Mester J, Redeuilh G. Mester J, et al. Anticancer Agents Med Chem. 2008 Dec;8(8):872-85. doi: 10.2174/187152008786847747. Anticancer Agents Med Chem. 2008. PMID: 19075570 Review.

6

Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases.

Redeuilh G, Attia A, Mester J, Sabbah M. Redeuilh G, et al. Among authors: mester j. Oncogene. 2002 Aug 22;21(37):5773-82. doi: 10.1038/sj.onc.1205753. Oncogene. 2002. PMID: 12173048

7

Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.

Gaben AM, Saucier C, Bedin M, Redeuilh G, Mester J. Gaben AM, et al. Among authors: mester j. Mol Endocrinol. 2004 Nov;18(11):2700-13. doi: 10.1210/me.2003-0133. Epub 2004 Aug 5. Mol Endocrinol. 2004. PMID: 15297603

8

p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.

Fritah A, Saucier C, Mester J, Redeuilh G, Sabbah M. Fritah A, et al. Among authors: mester j. Mol Cell Biol. 2005 Mar;25(6):2419-30. doi: 10.1128/MCB.25.6.2419-2430.2005. Mol Cell Biol. 2005. PMID: 15743834 Free PMC article.

9

Indirect participation of Hsp90 in the regulation of the cyclin E turnover.

Bedin M, Catelli MG, Cabanié L, Gaben AM, Mester J. Bedin M, et al. Among authors: mester j. Biochem Pharmacol. 2009 Jan 15;77(2):151-8. doi: 10.1016/j.bcp.2008.09.038. Epub 2008 Oct 14. Biochem Pharmacol. 2009. PMID: 18977205

10

Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation.

Attoub S, Arafat K, Kamel Hammadi N, Mester J, Gaben AM. Attoub S, et al. Among authors: mester j. Sci Rep. 2015 Aug 3;5:12759. doi: 10.1038/srep12759. Sci Rep. 2015. PMID: 26234648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters